From the Central Chronicle: “Chinese scientists have claimed success in developing a SARS vaccine that could be used among high-risk groups in the event of a large-scale outbreak again this spring, a report said.
Trials among 36 volunteers have proved ‘effective’ and ‘safe’ in the first-phase human tests begun on May 22, 2004, said Yin Weiping, Managing Director of Beijing-based Sinovac Biotech Co. Ltd., which has produced the vaccine.”
